BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ervin C, Joish VN, Evans E, Dibenedetti D, Reaney M, Preblick R, Castro R, Danne T, Buse JB, Lapuerta P. Insights Into Patients' Experience With Type 1 Diabetes: Exit Interviews From Phase III Studies of Sotagliflozin. Clinical Therapeutics 2019;41:2219-2230.e6. [DOI: 10.1016/j.clinthera.2019.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Danne T, Joish VN, Afonso M, Banks P, Sawhney S, Lapuerta P, Davies MJ, Buse JB, Lin D, Reaney M, Guillonneau S, Snoek FJ, Bailey TS, Polonsky WH. Improvement in Patient-Reported Outcomes in Adults with Type 1 Diabetes Treated with Sotagliflozin plus Insulin Versus Insulin Alone. Diabetes Technology & Therapeutics 2021;23:70-7. [DOI: 10.1089/dia.2020.0068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Deeks ED. Sotagliflozin: A Review in Type 1 Diabetes. Drugs 2019;79:1977-87. [PMID: 31761990 DOI: 10.1007/s40265-019-01230-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]